A promising emerging therapy (RIFAXIMIN) for the treatment of IBS Diarrhoea & SIBO
Enroll in FDC001
- Price Free
- Language English
Share your Case Studies
Come join our "Learn as you Teach" initiative to democratise healthcare learning by submitting your unique & interesting Case-Studies which will be reviewed by our global medical fraternity as well as an opportunity to be published in leading research journals.
Meet the instructor
Dr. Philip Abraham
MD, DNB, FCPS, FICP Consultant Gastroenterologist and Hepatologist, P D Hinduja Hospital, and Hinduja Healthcare Surgical, Mumbai. Retired Professor and Head, Department of Gastroenterology, K E M Hospital, Mumbai.